drugset / Trial / NCT07271693
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
The main purpose of this study is to evaluate the safety and tolerability of single and multiple ascending doses of RO7806881 in healthy participants.
Timeline
- Start
- 2025-12-22
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO7806881 | Unknown | — | — |
Indications
No indication recorded.